Skip to main content
. 2022 Mar 25;13:803706. doi: 10.3389/fphar.2022.803706

TABLE 7.

Univariate and multivariate analysis for predictors of ICPI-induced polymyalgia rheumatica.

Univariate analysis Or (95%CI) p Value Multivariate analysis Or (95%CI) p Value
Nivolumab
 Male 2.034 (0.850–4.871) 0.104 1.985 (0.828–4.759) 0.124
 Older adults (≥70 years old) 15.11 (4.642–49.149) <0.001 15.02 (4.615–48.87) <0.001
Pembrolizumab
 Male 0.216 (0.082–0.569) 0.001 0.214 (0.081–0.564) 0.002
 Older adults (≥70 years old) 1.940 (0.683–5.516) 0.205 1.980 (0.696–5.635) 0.200
Ipilimumab
 Male 2.645 (0.578–12.10) 0.193
 Older adults (≥70 years old) N.A. N.A.

CI, Confidence interval, N.A., Not available.